HDAC9 and Huntington disease: Using a similar compound another study found that HDAC inhibition reduced behavioural phenotypes and pathology as well as partially correcting transcriptional deregulation in a mouse model of HD [31] although other studies have questioned the specificity of the drug or did not reproduce all the beneficial effects found in the first study [44,45].